Päivärinta, Minna <br/><br/>
Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.  [electronic resource] 

 -  Pediatric diabetes  Jun 2008 
 - 83-90 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1399-5448 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-5448.2007.00341.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age of Onset<br/>Biomarkers--blood<br/>Blood Glucose--drug effects<br/>Body Height<br/>Body Weight<br/>C-Peptide--blood<br/>Child<br/>Child, Preschool<br/>Diabetes Mellitus, Type 1--blood<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--administration & dosage<br/>Insulin Glargine<br/>Insulin, Isophane--adverse effects<br/>Insulin, Long-Acting<br/>Male<br/>Reference Values<br/>Retrospective Studies